Novo Nordisk is investing billions of dollars into new plants in the port city Kalundborg on the Danish seaside. But just a ...

A more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk has had a major factory in Kalundborg, about an hour outside the Danish capital of Copenhagen, for 55 years. The company has pledged to invest 60 billion kroner ($6.7 billion ...

Europe's most valuable company has invested billions in Kalundborg on Denmark's coast - but it has many problems.

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Novo Nordisk’s blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter, sending shares 8.5% higher in early trade. Soaring popularity for its obesity drug has seen ...

Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared. But the Danish pharmaceutical company's origins were motivated by ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...

Kalundborg also has a health problem - it's in the highest 5% of Danish towns for children being overweight. Novo Nordisk, meanwhile, is now Europe's most valuable company with a revenue last year ...

Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk, whose profits from blockbuster weight-loss ...